Literature DB >> 7196689

Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients.

B J Maron, J S Gottdiener, S E Epstein.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7196689     DOI： 10.1016/0002-9149(81)90068-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  71 in total

1.  Echocardiographic pitfalls in the diagnosis of hypertrophic cardiomyopathy.

Authors:  K Prasad; J Atherton; G C Smith; W J McKenna; M P Frenneaux; P Nihoyannopoulos
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  No evidence for linkage of familial hypertrophic cardiomyopathy and chromosome 14q1 locus D14S26 in a Chinese family: evidence for genetic heterogeneity.

Authors:  Y L Ko; W P Lien; J J Chen; C W Wu; T K Tang; C C Liew
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

3.  MRI classification of asymmetric septal hypertrophic cardiomyopathy and its relation to the presence of risk factors.

Authors:  Yasuo Amano; Mitsunobu Kitamura; Morimasa Takayama; Masaki Tachi; Shinichiro Kumita
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-04       Impact factor: 2.357

4.  Hypertrophic cardiomyopathy in the elderly.

Authors:  L M Shapiro
Journal:  Br Heart J       Date:  1990-05

5.  Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction.

Authors:  M Fassbach; B Schwartzkopff
Journal:  Z Kardiol       Date:  2005-05

6.  Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1.

Authors:  María V Correa; Mariela B Nolly; Claudia I Caldiz; Gladys E Chiappe de Cingolani; Horacio E Cingolani; Irene L Ennis
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

7.  Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy.

Authors:  Shinro Matsuo; Yasuyuki Nakamura; Takayoshi Tsutamoto; Masahiko Kinoshita
Journal:  J Nucl Cardiol       Date:  2002 Jul-Aug       Impact factor: 5.952

8.  Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy.

Authors:  Sung-A Chang; Sang-Chol Lee; Yeon Hyeon Choe; Hye-Jin Hahn; Shin Yi Jang; Sung-Ji Park; Jin-Oh Choi; Seung Woo Park; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2012-10-25       Impact factor: 2.357

9.  Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.

Authors:  T Nishimura; S Nagata; T Uehara; T Morozumi; Y Ishida; T Nakata; O Iimura; C Kurata; Y Wakabayashi; H Sugihara; K Otsuki; T Wada; Y Koga
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

Review 10.  Athlete's heart or hypertrophic cardiomyopathy?

Authors:  Jörg Lauschke; Bernhard Maisch
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.